BMM
IBB icon

Berkshire Money Management’s iShares Biotechnology ETF IBB Stock Holding History

Berkshire Money Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-220
Closed -$27.8K – 82
2025
Q2 		$27.8K Buy
+220
New +$27K ﹤0.01% 147

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Berkshire Money Management's IBB Position: Q3 2025 in Review

Berkshire Money Management sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 220 shares — an estimated $27.8K sold.

Berkshire Money Management first reported a position in IBB in Q2 2025 and held it in 1 quarter. The position peaked at $27.8K in Q2 2025. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Berkshire Money Management reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Berkshire Money Management sold 220 iShares Biotechnology ETF shares in Q3 2025, an estimated $27.8K.
  • Berkshire Money Management first reported a position in iShares Biotechnology ETF in Q2 2025 and held it in 1 quarter.
  • Berkshire Money Management's iShares Biotechnology ETF position peaked at $27.8K in Q2 2025.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Berkshire Money Management's 13F filing for Q3 2025, filed 14 Oct 2025.